JUVENILE DERMATOMYOSITIS (JDM)
Clinical trials for JUVENILE DERMATOMYOSITIS (JDM) explained in plain language.
Never miss a new study
Get alerted when new JUVENILE DERMATOMYOSITIS (JDM) trials appear
Sign up with your email to follow new studies for JUVENILE DERMATOMYOSITIS (JDM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fish oil capsules could ease rare muscle disease
Disease control Recruiting nowThis study tests whether omega-3 fatty acid supplements from fish oil, combined with a healthy diet, can reduce disease activity in adults with dermatomyositis, a rare autoimmune disease causing muscle weakness and skin rashes. About 300 participants will take either fish oil cap…
Matched conditions: JUVENILE DERMATOMYOSITIS (JDM)
Phase: PHASE2 • Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Engineered immune cells aim to tame childhood autoimmune diseases
Disease control Recruiting nowThis early-stage trial tests a new type of CAR-T cell therapy in 11 children with severe rheumatic diseases like juvenile dermatomyositis and arthritis that haven't improved with standard treatments. The therapy uses specially engineered immune cells to target and calm the overac…
Matched conditions: JUVENILE DERMATOMYOSITIS (JDM)
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 18:49 UTC